Community Practice Connections™: Advances in Geographic Atrophy – Optimizing Diagnosis, Monitoring Progression, and Increasing Communication with Transformative Treatment on the Horizon
- David S. Boyer, MD
- Tina Mac Donald, OD, CDCES, FAAO
- Leo Semes, OD, FAAO
Geographic atrophy (GA) occurs as part of late-stage dry age-related macular degeneration (AMD), leading to severe vision loss. Until recently, lifestyle modification and nutritional supplements were the only available option to limit the progression of GA. Identification of the role of the complement system in disease pathogenesis has led to the development of new and emerging therapies with that can slow progression and preserve vision.
This Community Practice Connection™ program provides an in-depth review of some of the key highlights from the Controversies in Modern Eye Care meeting held in April 2023. This unique and engaging multi-media activity is ideal for the community-based optometrist and focuses on the practical aspects of traditional and pharmacologic treatment of geographic atrophy. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.
This educational activity is directed toward optometrists, ophthalmologists and other healthcare professionals who would be involved in the management of patients suffering from geographic atrophy.
Upon successful completion of this activity, you should be better prepared to:
- Use appropriate testing methods to diagnose and monitor geographic atrophy
- Identify factors that negatively impact quality of life for patients with geographic atrophy
- Describe the role of complement system dysregulation in the development of geographic atrophy
- Evaluate emerging evidence for the use of targeted therapies in the treatment of geographic atrophy